NCT06674590 Effects of Motor Relearning Program Versus Proprioceptive Neuromuscular Facilitation on Balance and Gait in Stroke
| NCT ID | NCT06674590 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Chronic Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 26 participants |
| Start Date | 2024-06-20 |
| Primary Completion | 2024-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 26 participants in total. It began in 2024-06-20 with a primary completion date of 2024-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A randomized control trial will be done on diagnosed stroke patients of chronic stage in DHQ Hospital Mirpur and FF Hospital Rawalpindi physical therapy Department.The purpose of the study is to determine Effects of Motor Relearning Program Versus Proprioceptive Neuromuscular Facilitation on Balance and Gait in Stroke . Subjects will complete Berg Balance Scale (BBS). 10-meter walk test for gait speed will be used for measuring walking speed in meters per second over a short distance, Timed-Up-And-Go (TUG) Test will be used for test of functional mobility and gait parameter. All these measures will be taken at baseline, then after 6 weeks of intervention. There will be 4 sessions per week. The control group will receive Group Motor relearning programe while the Study Group (B) will receive Proprioceptive Neuromuscular Facilitation(PNF)
Eligibility Criteria
Inclusion Criteria: * more than 6 month post stroke * both male and female * Can ambulate 25 feet/10 meter (with or without assistive device). * Age between 25 to 65 years. * Grades for MAS (Grade 2 0r less )/stage of brunstrom approach (stage 4 or up ) Exclusion Criteria: * History of neurologic disease other than the chronic stroke. * Orthopedic disorder involving any joint of lower limbs that interfere with study. * Gross visuospatial deficits . * Unhealed fracture of lowerlimb . * Peripheral arterial occlusive disease. * Uncontrolled hypertension and diabetes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06674590 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 65 Years, studying Chronic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06674590 currently recruiting?
Yes, NCT06674590 is actively recruiting participants. Contact the research team at asiftuseef73@gmail.com for enrollment information.
Where is the NCT06674590 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT06674590 clinical trial?
NCT06674590 is sponsored by Foundation University Islamabad. The trial plans to enroll 26 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.